FDA Inspection
Lexia LLCLexia LLC – FDA Inspection, Sep 29, 2025
Record Details
This FDA Inspection record concerns Lexia LLC, with an inspection on September 29, 2025, issued by the New Orleans District Office, covering human drugs.
View Company Profile
ID · 1c42bb59-a8ac-4aa9-9303-f20790ec2e7f
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1284722
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
8- 21 CFR 211.110(a)Control procedures to monitor and validate performance
- 21 CFR 211.113(a)Procedures for non-sterile drug products
- 21 CFR 211.122(a)Written procedures describing in detail
- 21 CFR 211.165(a)Testing and release for distribution
- 21 CFR 211.166(a)Lack of written stability program
- 21 CFR 211.188(b)Batch production and Batch Control Record Requirements
- 21 CFR 211.22(a)Lack of quality control unit
- 21 CFR 211.80(a)Procedures To Be in Writing
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Lexia LLC
1| Date | Classification | Office | Project area |
|---|---|---|---|
| March 7, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Lexia LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.